ACVRL1 and hereditary hemorrhagic telangiectasia: For instance, individuals with heterozygous loss-of-function mutations in ALK1 or ENG develop hereditary haemorrhagic telangiectasia (HHT)15,16, and BMP9 mutations have been identified in patients with a phenotype similar to HHT17.